Management of primary biliary cirrhosis

Hepatology

Volumn 31, Issue 4, 2000, Pages 1005-1013

  Jenny Heathcote, E ^a,b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COLESTYRAMINE; MITOCHONDRION ANTIBODY; RIFAMPICIN; URSODEOXYCHOLIC ACID;

ARTICLE; CHOLESTASIS; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; HUMAN; HYPERBILIRUBINEMIA; HYPERCHOLESTEROLEMIA; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; OSTEOPOROSIS; PORTAL HYPERTENSION; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PRURITUS; SJOEGREN SYNDROME;

EID: 17544379813     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/he.2000.5984     Document Type: Article

References (13)

1. Gross PA, Banett TL, Dellinger P, Krause PJ, Martone WJ, McGowan Jr JE, Sweet RL, et al. Infectious Disease Society of America quality standards for infectious diseases: purpose of quality standards for infectious diseases. Clin Infect Dis 1994;18:421.
2. Gershwin ME, Mackay IR. Primary biliary cirrhosis: paradigm or paradox for autoimmunity. Gastroenterology 1990;99:822-833.
3. Shapiro JM, Smith H, Schaffner F. Serum bilirubin: a prognostic factor in primary biliary- cirrhosis. Gut 1979;20:137-140.
4. MacCarty RL, LaRusso NF, Wiesner RH, Ludwig J. Primary sclerosing cholangitis: findings on cholangiography and pancreatography. Radiology 1983;149:39-44.
5. Doniach D, Roitt IM, Walker JG, Sherlock S. Tissue antibodies in primary biliary cirrhosis, active chronic (lupoid) hepatitis, cryptogenic cirrhosis and other liver diseases and their clinical implications. Clin Exp Immunol 1966;1:237-262.
6. Fussey S, Guest JR, James O, Bassendine MF, Yeaman SJ. Identification and analysis of the major M2 autoantigens in primary biliary cirrhosis. Proc Natl Acad Sci U S A 1988;85:8654-8658.
7. Jorde R, Rekvig OP, Bostad L. A follow-up study of 68 patients with anti-mitochondrial antibodies (AMA). Acta Med Scand 1986;220:241-247.
8. Munoz LE, Thomas HC, Scheuer PJ, Doniach D, Sherlock S. Is mitochondrial antibody diagnostic of primary biliary cirrhosis? Gut 1981;22:136-140.
9. Kitami N, Komada T, Ishu H, Shimizu H, Adachi H, Yamaguchi Y, Kitamura T, et al. Immunological study of anti-M2 in antimitochondrial antibody-negative primary biliary cirrhosis. Intern Med 1995;34:496-501.
10. Caldwell SH, Leung PS, Spivey JR, Prindwelle T, de Medina M, Saicheur T, Rowley M, et al. Anitmitochondrial antibodies in kindreds of patients with primary biliary cirrhosis: antimitochondrial antibodies are unique in clinical disease and are absent in asymptomatic family members. HEPATOLOGY 1992;16:899-905.
11. Brind AM, Bray GP, Portmann BC, Williams R. Prevalence and pattern of familial disease in primary biliary cirrhosis. Gut 1995;36:615-617.
12. Vrethem M, Skogh T, Berlin G, Ernerudh J. Autoantibodies versus clinical symptoms in blood donors. J Rheumatol 1992;19:1919-1921.
13. Zauli D, Schrumpf E, Crespi C, Cassani F, Fausa O, Aadland E. An autoantibody profile of primary sclerosing cholangitis. J Hepatol 1987;5:14-18.